Search results
Results From The WOW.Com Content Network
Common clinical features of ataxic dysarthria include abnormalities in speech modulation, rate of speech, explosive or scanning speech, slurred speech, irregular stress patterns, and vocalic and consonantal misarticulations. [13] [14] Ataxic dysarthria is associated with damage to the left cerebellar hemisphere in right-handed patients. [15]
Side effects are typical of hypnotic benzodiazepines, though temazepam has more pronounced CNS depressant effects, and include somnolence, sedation, dizziness, fatigue, ataxia, headache, lethargy, impairment of memory and learning, longer reaction time and impairment of motor functions (including coordination problems), [26] slurred speech ...
Slurred speech; Extrapyramidal symptoms including dyskinesias (acute & delayed) Dystonic reactions; Cogwheel rigidity; Emotional lability; Psychosis; Suicidal ideation; Ataxias; Transient difficulty with recall; Serotonin syndrome; Parkinsonism; Restless leg syndrome; Restlessness; Eye pain; Altered sense of smell; Photophobia; Pressure on eyes ...
Sudden weakness, slurred speech, visual disturbances, or stroke. Dyslipidemia can cause plaque to build up in the arteries responsible for carrying blood to your brain.
An overdose of pregabalin usually consists of severe drowsiness, severe ataxia, blurred vision, slurred speech, uncontrollable jerking motions , and anxiety. [92] In one case study, macular detachment was reported with overdose [ 93 ] Despite these symptoms an overdose is not usually fatal unless mixed with another CNS depressant .
Around 70% of patients with narcolepsy also experience cataplexy episodes, according to U.S. government data, which can cause slurred speech or muscle weakness triggered by intense emotions.
You also might feel confused, drowsy, exhausted, or have slurred speech. ... Diabetes medications, general anesthesia for surgery, and chemotherapy medications are more likely to cause chills.
Nuedexta is an FDA approved medication for pseudobulbar affect. Dextromethorphan, an N-methyl-D-aspartate receptor antagonist, inhibits glutamatergic transmission in the regions of the brainstem and cerebellum, which are hypothesized to be involved in pseudobulbar symptoms, and acts as a sigma ligand, binding to the sigma-1 receptors that ...